eli lilly gip glp-1 and phase results 2 on their dual GIP/GLP1 receptor agonist LY3298176 Eli Lilly's Anticipated Weight Loss

The Weight Loss Medication Craze Weight loss medications, especially the ones in a class of medications called Glucagon-like Peptide 1 (GLP-1) agonists, are becoming increasingly popular

The findings showed increased risk of osteoporosis (relative risk 1.29), gout (relative risk 1.12), and, most strikingly, osteomalacia, which is a softening of the bones, with a relative risk of 2.55 [4]

All you have to do is turn on the news or jump on social media and youll see people across the nation singing the praises of these new medications

Want Real GLP-1 Care Instead of OTC Supplements

The second common error is overstating Jardiance's weight-loss potential

Shklyar I, Pasternak A, Kapur K, Darras BT, Rutkove SB